Brain charts in children and adolescents with neurofibromatosis type 1

The Defense Health Agency awarded a $697,766 Project Grant under the Military Medical Research and Development program (CFDA 12.420) to the Murdoch Children's Research Institute in Australia. The grant, awarded on July 15, 2024, will fund a 3-year research project titled "BRAIN CHARTS IN CHILDREN AND ADOLESCENTS WITH NEUROFIBROMATOSIS TYPE 1". The project aims to conduct biomedical research to better understand and characterize brain development in children and adolescents with neurofibromatosis type 1, a genetic disorder that can impact the nervous system. The research activities may include clinical trials, data analysis, biospecimen collection, patient assessments, and scientific collaboration with partners. This award builds upon Murdoch Children's Research Institute's expertise in pediatric health research and its history of receiving federal grants and subawards from agencies like the National Institutes of Health to study a range of childhood diseases and disorders.